ISSN: 1885-5857 Impact factor 2023 5.9
Vol. 71. Num. 12.
Pages 1090 (December 2018)

Letter to the editor
Cost-effectiveness of Evolocumab. Response

Coste-efectividad del evolocumab. Respuesta

Antonio Olry de Labry LimaabcAntonio Matas HocesdEmilio Jesús Alegre del ReyeVicente Gimeno Ballesterf
Rev Esp Cardiol. 2018;71:108910.1016/j.rec.2018.04.028
Carlos Escobar, Vivencio Barrios

Options

Identify yourself

Not yet a subscriber to the journal?

Purchase access to the article

By purchasing the article, the PDF of the same can be downloaded

Price: 19,34 €

Phone for incidents

Monday to Friday from 9am to 6pm (GMT+1) except for the months of July and August, which will be from 9am to 3pm

Calls from Spain 932 415 960
Calls from outside Spain +34 932 415 960
Copyright © 2018. Sociedad Española de Cardiología
Are you a healthcare professional authorized to prescribe or dispense medications?